KORSCH introduces next-generation mid-range tablet press
X 3 Tablet Press incorporates production capabilities and versatility traditionally limited to large-scale production machines.
KORSCH is introducing a mid-range tablet press incorporating innovative features previously available only on large production machines.
The new X 3 Tablet Press is a single-sided rotary press that redefines this market segment, with flexible technology and a new approach to architectural and ergonomic design.
Suitable for product development, scale-up, clinical production, mid-range production and continuous manufacturing, the next-generation X 3 Tablet Press is available in two models. The X 3 SFP is a dedicated single-layer press capable of 266,400 tablets/hour, whereas the X 3 MFP offers flexible single-layer (266,400 tablets/hour) and bi-layer (133,200 tablets/hour) production capability.
The X 3 incorporates a flexible manufacturing experience atypical for its size, with an integrated electrical cabinet, torque drive, fully sealed design, and unsurpassed accessibility for cleaning, changeovers and maintenance.
Installation options include a conventional in-room layout, through-the-wall mounting, and a portable equipment platform. The X 3 offers a range of product containment configurations, including OEB 3, as well as OEB 4/5 with full wash-in-place and high-containment execution.
In addition, the X 3's exchangeable turret technology allows for an extremely fast transition between products, and the ability to produce a tablet of any size and shape.
For mid-range manufacturing, the X 3 offers a long filling length and large, variable-speed power feeder for precision die filling at extremely high speeds. For changeovers, superior compression zone access, smooth surfaces, and minimal fast change parts yield an expedited process for maximized machine uptime.
The unique KORSCH machine structure provides excellent visibility and unlimited access to the compression zone for streamlined changeover and turret exchange. It is a fully sealed machine with no heat transfer to the compression zone of the press, or to the compression room. This closed design also eliminates potential contamination in the machine base or electrical cabinet, and further expedites the changeover process.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance